Role of traslational research in squamous cell carcinoma of the head and neck: is it possible to improve the therapeutic scenario? WCRJ 2015; 2 (2): e520
Selected Pharmacogenetic panel test for toxicity prevention of drug-drug interactions between Highly Active Antiretroviral Therapy (HAART) and antiblastic chemotherapy WCRJ 2015; 2 (1): e492
Hepatocellular carcinoma: an overview of clinico-pathological and molecular perspectives WCRJ 2015; 2 (1): e485
Pharmacogenomics of Cytochrome P450 Family enzymes: implications for drug-drug interaction in anticancer therapy WCRJ 2015; 2 (1): e483
Malignant hepatic tumors in pediatric patients: clinical and radiological features WCRJ 2015; 2 (1): e481
Pre-operative chemotherapy for colorectal cancer with liver metastases and conversion therapy WCRJ 2015; 2 (1): e473
Fertility and pregnancy after breast cancer treatment: evidence-based answers to the main questions that patients ask WCRJ 2014; 1 (4): e413
Gonadotoxic effects of breast cancer treatment and fertility protection strategies: evidence based answers to the main questions the patients ask WCRJ 2014; 1 (4): e409